The agouti-related protein decapeptide (Yc[CRFFNAFC]Y) possesses agonist activity at the murine melanocortin-1 receptor

Peptides

Volumn 21, Issue 5, 2000, Pages 683-689

  Haskell Luevano, Carrie ^a   Monck, Eileen K ^a   Wan, Y P ^b   Schentrup, Anzeela M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NEN Life Science Products   (United States)

Author keywords

Melanocyte stimulating hormone; Agouti related protein; MC1R; MC4R; Melanocortin; Melanotropin; Obesity

Indexed keywords

INTERMEDIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; PEPTIDE; RECEPTOR BLOCKING AGENT;

AGONIST; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; IC 50; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; HUMANS; MICE; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; SEQUENCE HOMOLOGY, AMINO ACID;

AGOUTI; MURINAE;

EID: 0034039621     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00194-7     Document Type: Article

References (47)

1. Bolin K.A., Anderson D.J., Trulson J.A., et al. NMR structure of a minimized human agouti related protein prepared by total chemical synthesis. FEBS Lett. 451:1999;125-131.
2. Bowen W.P., Jerman J.C. Nonlinear regression using spreadsheets. Trends Pharmacol Sci. 16:1995;413-417.
3. Broberger C., Johansen J., Johansson C., Schalling M., Hokfelt T. The neuropeptide Y/Agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA. 95:1998;15043-15048.
4. Bultman S.J., Michaud E.J., Woychick R.P. Molecular characterization of the mouse agouti locus. Cell. 71:1992;1195-1204.
5. Bures E.J., Hui J.O., Young Y., et al. Determination of disulfide structure in agouti-related protein (AGRP) by stepwise reduction and alkylation. Biochemistry. 37:1998;12172-12177.
6. Castrucci A.M.L., Hadley M.E., Sawyer T.K., et al. α-Melanotropin. The minimal active sequence in the lizard skin bioassay. Gen Comp Endocrinol. 73:1989;157-163.
7. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., Cone R.D. Exocrine gland dysfunction in MC5-R deficient mice evidence for coordinated regulation of exocrine gland functions by melanocortin peptides . Cell. 91:1997;789-798.
8. Chen W., Shields T.S., Stork P.J.S., Cone R.D. A colorimetric assay for measuring activation of Gs- and Gq-coupled signaling pathways. Anal Biochem. 226:1995;349-354.
9. Chhajlani V., Muceniece R., Wikberg J.E.S. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun. 195:1993;866-873.
10. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
11. Cone R.D., Lu D., Kopula S., et al. The melanocortin receptors agonists, antagonists, and the hormonal control of pigmentation . Recent Prog Horm Res. 51:1996;287-318.
12. Eberle A.N. In The melanotropins: chemistry, physiology and mechanisms of action . 1988;Karger, Basel.
13. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (London). 385:1997;165-168.
14. Gantz I., Konda Y., Tashiro T., et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem. 268:1993;8246-8250.
15. Gantz I., Miwa H., Konda Y., et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem. 268:1993;15174-15179.
16. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun. 200:1994;1214-1220.
17. Graham M., Shutter J.R., Sarmiento U., Sarosi I., Stark K.L. Overexpression of AGRT leads to obesity in transgenic mice. Nat Genet. 17:1997;273-274.
18. Haskell-Luevano C., Chen P., Li C., et al. Characterization of the neuroanatomical distribution of agouti related protein (AGRP) immunoreactivity in the rhesus monkey and the rat. Endocrinology. 140:1999;1408-1415.
19. Haskell-Luevano C., Hendrata S., North C., et al. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. J Med Chem. 40:1997;2133-2139.
20. Haskell-Luevano C., Sawyer T.K., Hendrata S., et al. Truncation studies of α-melanotropin peptides identifies tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides. 17:1996;995-1002.
21. Haskell-Luevano C., Shenderovich M.D., Sharma S.D., Nikiforovich G.V., Hadley M.E., Hruby V.J. Design, synthesis, biology, and conformations of bicyclic α-melanotropin peptide analogues. J Med Chem. 38:1995;1736-1750.
22. 2 with bulky aromatic amino acids at position 7 show high antagonist potency, and selectivity at specific melanocortin receptors. J Med Chem. 38:1995;3454-3461.
23. Hruby V.J., Wilkes B.C., Hadley M.E., et al. α-Melanotropin. The minimal active sequence in the frog skin bioassay. J Med Chem. 30:1987;2126-2130.
24. Huszar D., Lynch C.A., Fairchild-Huntress V., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
25. Kaiser E., Colescott R.L., Bossinger C.D., Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 34:1970;595-598.
26. Kiefer L.L., Ittoop O.R., Bunce K., et al. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors. Biochemistry. 36:1997;2084-2090.
27. Kiefer L.L., Veal J.M., Mountjoy K.G., Wilkison W.O. Melanocortin receptor binding determinants in the agouti protein. Biochemistry. 37:1998;991-997.
28. Lu D., Väge D.I., Cone R.D. A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. Mol Endocrinol. 12:1998;592-604.
29. Lu D., Willard D., Patel I.R., et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature (London). 371:1994;799-802.
30. Miller M.W., Duhl D.M., Vrieling H., et al. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7:1993;454-467.
31. Mountjoy K.G. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides. Mol Cell Endocrinol. 102:1994;R7-R11.
32. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol. 8:1994;1298-1308.
33. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
34. Ollmann M.M., Wilson B.D., Yang Y.-K., et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:1997;135-138.
35. Perry W.L., Hustad C.M., Swing D.A., Jenkins N.A., Copeland N.G. A transgenic mouse assay for agouti protein activity. Genetics. 140:1995;267-274.
36. Perry W.L., Nakamura T., Swing D.A., et al. Coupled site-directed mutagenesis/transgenesis identifies important functional domains of the mouse agouti protein. Genetics. 144:1996;255-264.
37. 2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett. 428:1998;59-62.
38. Richards NGJ, Thirumoorthy R, Haskell-Luevano C, Schentrup AM, Edison AS. Structure, and conformational properties of a functional antagonist of the melanocortin-4 receptor. Am Chem Soc National Meeting, New Orleans, LA, 1999. p. 258. Abstract.
39. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., et al. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA. 90:1993;8856-8860.
40. Schild H.O. pA, a new scale for the measurement of drug antagonism. Br J Pharmacol. 2:1947;189-206.
41. Schiöth H.B., Muceniece R., Larsson M., et al. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur J Pharmacol. 319:1997;369-373.
42. Shutter J.R., Graham M., Kinsey A.C., Scully S., Lüthy R., Stark K.L. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11:1997;593-602.
43. Stewart JM, Young JD. In: Solid phase peptide synthesis. Rockford, IL: Pierce Chemical, 1984.
44. Tota M.R., Smith T.S., Mao C., et al. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors. Biochemistry. 38:1999;897-904.
45. Willard D.H., Bodnar W., Harris C., et al. Agouti structure and function characterization of a potent α-melanocyte stimulating hormone receptor antagonist . Biochemistry. 34:1995;12341-12346.
46. Yang Y.-K., Ollmann M.M., Wilson B.D., et al. Effects of recombinant Agouti signaling protein on melanocortin action. Mol Endocrinol. 11:1997;274-280.
47. Yang Y.-K., Thompson D.A., Dickinson C.J., et al. Characterization of Agouti-related protein binding to melanocortin receptors. Mol Endocrinol. 13:1999;148-155.